Compare Marqeta Inc (MQ) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marqeta Inc vs Sana Biotechnology Inc — how do they compare? Marqeta Inc trades at $17.22 (market cap $1.85B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Marqeta Inc is far larger — about 2.1× Sana Biotechnology Inc's market cap. Which is the better fit depends on your goals.
| MQ | SANA | |
|---|---|---|
Market Cap | $1.85B | $873.84M |
Sector | Technology | Health |
52-Week High | $27.32 | $5.92 |
52-Week Low | $15.04 | $2.68 |
Enterprise Value | $1.15B | $848.03M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Marqeta Inc
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
Read more on MQ →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
